172 related articles for article (PubMed ID: 18537614)
1. Anticancer drug discovery targeting DNA hypermethylation.
Yu N; Wang M
Curr Med Chem; 2008; 15(14):1350-75. PubMed ID: 18537614
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL
PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy.
Gowher H; Jeltsch A
Cancer Biol Ther; 2004 Nov; 3(11):1062-8. PubMed ID: 15539938
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling and virtual screening of DNA methyltransferase inhibitors.
Medina-Franco JL; Yoo J
Curr Pharm Des; 2013; 19(12):2138-47. PubMed ID: 23016844
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
Gnyszka A; Jastrzebski Z; Flis S
Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
[TBL] [Abstract][Full Text] [Related]
8. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
[TBL] [Abstract][Full Text] [Related]
10. Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells.
Adams PD; Cairns P
Cancer Biol Ther; 2003; 2(5):557-8. PubMed ID: 14614326
[No Abstract] [Full Text] [Related]
11. Towards a pharmacology of DNA methylation.
Szyf M
Trends Pharmacol Sci; 2001 Jul; 22(7):350-4. PubMed ID: 11431029
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic drug discovery: targeting DNA methyltransferases.
Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
[TBL] [Abstract][Full Text] [Related]
13. Evidence of inhibition of DNA methylation by fludarabine.
Wyczechowska D; Czyz M; Fabianowska-Majewska K
Adv Exp Med Biol; 2000; 486():349-53. PubMed ID: 11783513
[No Abstract] [Full Text] [Related]
14. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors.
Garella D; Atlante S; Borretto E; Cocco M; Giorgis M; Costale A; Stevanato L; Miglio G; Cencioni C; Fernández-de Gortari E; Medina-Franco JL; Spallotta F; Gaetano C; Bertinaria M
Chem Biol Drug Des; 2016 Nov; 88(5):664-676. PubMed ID: 27225604
[TBL] [Abstract][Full Text] [Related]
16. Novel anticancer drug curaxin CBL0137 impairs DNA methylation by eukaryotic DNA methyltransferase Dnmt3a.
Sergeev A; Vorobyov A; Yakubovskaya M; Kirsanova O; Gromova E
Bioorg Med Chem Lett; 2020 Aug; 30(16):127296. PubMed ID: 32631516
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.
Fahy J; Jeltsch A; Arimondo PB
Expert Opin Ther Pat; 2012 Dec; 22(12):1427-42. PubMed ID: 23033952
[TBL] [Abstract][Full Text] [Related]
18. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.
Honeywell RJ; Sarkisjan D; Kristensen MH; de Klerk DJ; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2018; 37(12):696-708. PubMed ID: 30663502
[TBL] [Abstract][Full Text] [Related]
20. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
Liang Z; Zhu Y; Liu X; Hu G
Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
